author-photo

Johan Vansteenkiste

Katholieke Universiteit Leuven
The Catholic University of America

592

Papers

42338

Citations

Citation Trend

Filter By

Papers (591) Sort By

Journal Conference Others

P47.17 Capmatinib vs Docetaxel in Pretreated Patients With MET Exon 14 Skipping–mutated Stage IIIB/IIIC or IV NSCLC (GeoMETry-III)

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P01.21 ANSELMA: Antiangiogenic Second Line Lung Cancer Meta-Analysis on Individual Patient Data in Non-Small Cell Lung Cancer, Again Relevant in ICI Era

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
186TiP An open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1283P Predicting the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) by combining clinical and radiomic features

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Five-year survival outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC: An update from the PACIFIC trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (13)
1362TiP Capmatinib versus docetaxel in pretreated patients with MET exon 14 skipping-mutated locally advanced or metastatic NSCLC: The GeoMETry-III phase III study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Genetic landscape of patients with ALK-rearranged non–small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
MO01.21 Phase 2 GEOMETRY Mono-1 Study: Capmatinib in Patients with METex14-mutated Advanced Non-Small Cell Lung Cancer who Received Prior Immunotherapy

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial.

2021 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous Non-Small Cell Lung Cancer: A Phase 1B Study

2021
Show All
- Source
- Cite
- Save
Citations (0)